They are identified at low numbers in various cancer types, such as those of the endometrium, stomach, liver and adrenal gland, but are most frequently observed in colorectal cancers (63 in about 2100 CRC patients profiled for ZNRF3, i.e. ± 3%). Here, ZNRF3 is linked to colorectal carcinoma.